Moderna
MRNA
#1676
Rank
S$12.67 B
Marketcap
$32.78
Share price
1.68%
Change (1 day)
-76.95%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -$12.56

According to Moderna 's latest financial reports the company's current EPS (TTM) is -$11.92. In 2022 the company made an earnings per share (EPS) of $27.55 a decrease over its 2021 EPS that were of $39.50.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.56-145.57%
2022$27.55-30.25%
2021$39.50-1660.82%
2020-$2.5325.16%
2019-$2.0237.04%
2018-$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.20-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.38-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.95-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.36-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.88-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.22-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.37-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA